Current and Emerging Inhaled Antibiotics for Chronic Pulmonary <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i> Infections in Cystic Fibrosis
Characterized by impaired mucus transport and subsequent enhanced colonization of bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic fibrosis (CF). <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) and <i>Staphylococcus aureus&...
Saved in:
Main Authors: | Danni Li (Author), Elena K. Schneider-Futschik (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Combination of Low-Frequency Ultrasound and Antibiotics Improves the Killing of In Vitro <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> Biofilms
by: Lasse Kvich, et al.
Published: (2022) -
Virulence of <i>Pseudomonas aeruginosa</i> in Cystic Fibrosis: Relationships between Normoxia and Anoxia Lifestyle
by: Rosanna Papa, et al.
Published: (2023) -
<i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i> Display Differential Proteomic Responses to the Silver(I) Compound, SBC3
by: Magdalena Piatek, et al.
Published: (2023) -
Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i>
by: Emma Reece, et al.
Published: (2021) -
Specificity in the Susceptibilities of <i>Escherichia coli</i>, <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i> Clinical Isolates to Six Metal Antimicrobials
by: Natalie Gugala, et al.
Published: (2019)